Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$580M |
| 2 |
Broadcom
AVGO
|
+$511M |
| 3 |
Tesla
TSLA
|
+$471M |
| 4 |
American International
AIG
|
+$438M |
| 5 |
Advanced Micro Devices
AMD
|
+$337M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$444M |
| 2 |
Synopsys
SNPS
|
+$348M |
| 3 |
Pinduoduo
PDD
|
+$326M |
| 4 |
NetEase
NTES
|
+$314M |
| 5 |
DexCom
DXCM
|
+$302M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.37% |
| 2 | Financials | 12.15% |
| 3 | Industrials | 11.37% |
| 4 | Healthcare | 11.18% |
| 5 | Consumer Discretionary | 10.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3651
Cue Biopharma
CUE
$128M
| $40.5K | ﹤0.01% |
511
-77
| -13% | -$5.5K |
|
3652
SKYX Platforms
SKYX
$149M
| $40.4K | ﹤0.01% |
25,270
-39,200
| -61% | -$61K |
|
3653
NuScale Power
SMR
$2.98B
| $39.2K | ﹤0.01% |
11,907
-3,654
| -23% | -$13K |
|
|
HLTH
3654
DELISTED
Cue Health Inc. Common Stock
HLTH
| $38.5K | ﹤0.01% |
237,134
+65
| +0% | +$22 |
|
|
ORGN
3655
DELISTED
Origin Materials
ORGN
| $38.4K | ﹤0.01% |
1,532
+209
| +16% | +$5.99K |
|
3656
Scilex Holding
SCLX
$46.4M
| $38.4K | ﹤0.01% |
538
| – | – |
|
3657
KORU Medical Systems
KRMD
$189M
| $38.1K | ﹤0.01% |
15,518
-40,921
| -73% | -$97.5K |
|
3658
Cartesian Therapeutics
RNAC
$227M
| $37.6K | ﹤0.01% |
1,818
-783
| -30% | -$23.4K |
|
|
NBP
3659
NovaBridge Biosciences American Depositary Shares
NBP
$190M
| $37.5K | ﹤0.01% |
19,763
-64,399
| -77% | -$96.2K |
|
3660
374Water
SCWO
$39.2M
| $37.3K | ﹤0.01% |
2,630
-3,278
| -55% | -$43.8K |
|
|
CARM
3661
DELISTED
Carisma Therapeutics
CARM
| $37.3K | ﹤0.01% |
12,732
+2,453
| +24% | +$7.29K |
|
3662
PMV Pharmaceuticals
PMVP
$60.3M
| $37.2K | ﹤0.01% |
+11,986
| New | +$31.7K |
|
|
TGAN
3663
DELISTED
Transphorm, Inc. Common Stock
TGAN
| $36.9K | ﹤0.01% |
10,118
-1,796
| -15% | -$4.92K |
|
|
BHIL
3664
DELISTED
Benson Hill, Inc.
BHIL
| $36.2K | ﹤0.01% |
5,947
+1,143
| +24% | +$10.2K |
|
3665
Akebia Therapeutics
AKBA
$362M
| $36.2K | ﹤0.01% |
29,171
+5,353
| +22% | +$5.46K |
|
|
LENZ
3666
LENZ Therapeutics
LENZ
$181M
| $35.2K | ﹤0.01% |
1,917
+234
| +14% | +$3.86K |
|
|
MLGO
3667
MicroAlgo
MLGO
$44.3M
| $33.8K | ﹤0.01% |
+6
| New | +$107K |
|
|
NOTE
3668
DELISTED
FiscalNote
NOTE
| $33.4K | ﹤0.01% |
2,443
+311
| +15% | +$5.13K |
|
3669
Aclaris Therapeutics
ACRS
$743M
| $33.2K | ﹤0.01% |
31,657
-8,061
| -20% | -$24.6K |
|
|
OMGA
3670
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $32.6K | ﹤0.01% |
10,819
-2,553
| -19% | -$5.17K |
|
3671
Redwire
RDW
$2.02B
| $32.4K | ﹤0.01% |
11,383
-524
| -4% | -$1.43K |
|
3672
Golden Heaven Group Holdings
GDHG
$26.2M
| $31.9K | ﹤0.01% |
2
| – | – |
|
3673
Design Therapeutics
DSGN
$788M
| $29K | ﹤0.01% |
+10,937
| New | +$25.1K |
|
3674
Trevi Therapeutics
TRVI
$2.61B
| $26.6K | ﹤0.01% |
19,888
+3,842
| +24% | +$5.82K |
|
3675
Standard BioTools
LAB
$351M
| $26.5K | ﹤0.01% |
+11,985
| New | +$25.6K |
|
Similar funds
Invesco's Q4 2023 Portfolio in Review
As of Q4 2023, Invesco held 3,965 positions worth $420B, up 13% from $371B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Invesco's Q4 2023 filing shows 126 new, 1,970 increased, 1,592 reduced and 143 closed positions. Its largest new stake was Veralto: 4,358,553 shares worth $359M. The largest sale was Pioneer Natural Resource Co., an estimated $444M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Industrials.
- Invesco's largest Q4 2023 buy was Veralto: 4,358,553 shares worth $359M.
- Invesco added most to Texas Instruments in Q4 2023, an estimated $580M increase.
- Invesco's biggest Q4 2023 reduction was Pioneer Natural Resource Co., cutting an estimated $444M.
- Invesco fully exited Activision Blizzard in Q4 2023, selling an estimated $186M.
- Invesco's ten largest holdings make up 15% of its $420B portfolio in Q4 2023.
- Invesco opened 126 new positions and closed 143 in Q4 2023.
- Invesco's portfolio value rose 13% quarter-over-quarter to $420B.
Based on Invesco's 13F filing for Q4 2023, filed 13 Feb 2024.